ClinicalTrials.gg
Status unknownNCT05339906ZOVUpdated Apr 21, 2022

Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band

An interventional study of ZOV.ai digital therapy candidate in Stuttering, Adult and Stammering, sponsored by Oles Honchar Dnipro National University. Status unknown at 1 site in Ukraine. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-21.

Sponsored by Oles Honchar Dnipro National University · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled May 2021, registered Mar 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

In this study, the investigators will research the efficacy of a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes.

Read the detailed description

Stuttering is a speech disorder that affects more than 70 million people worldwide, limiting their ability to communicate and socialize. During recent decades, several studies have demonstrated a link between stuttering and a deficit of β EEG spectral power.

In this study, the investigators will research the efficacy of a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes. Participants are adults with stuttering and without speech disfluencies from the control group will expose to euphonic binaural stimuli for 5 minutes. The brain electrical activity patterns (EEG) and ECG bio-signals will record prior to, during, and after exposure.

02

Conditions studied

  • Stuttering, Adult
  • Stammering

Keywords

  • Speech disorders
  • Binaural beats
  • Auditory stimulation
  • Stuttering
  • Stammering
03

In context

Stuttering

74 studies on the registry are indexed under Stuttering; 23 are open to participants now.

This study's planned enrollment of 25 is below the median of 44 across 57 interventional studies indexed under Stuttering.

Browse Stuttering studies →

Lead sponsor

This is the only study on the registry with Oles Honchar Dnipro National University as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with stuttering (stammering) symptoms;

Exclusion criteria

Exclusion Criteria:

  • Hearing disabilities;
  • Applying other drugs or devices simultaneously;
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    ZOV.ai digital therapy candidate

    The arm will use a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes to improve stuttering symptoms. The total length of the audio stimuli is 5 minutes.

    Device: ZOV.ai digital therapy candidate

Interventions

  • DeviceZOV.ai digital therapy candidate

    ZOV.ai is a novel auditory neuro modulating technology that leverages euphonic music tracks with broad-spectrum binaural beats to induce selective EEG spectral power changes to improve stuttering symptoms

06

What researchers measure

Primary outcomes

  1. Speech disfluencies

    The total number of repetitions, blocks and prolongations during the speech (assessed by speech therapist) measured before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

Secondary outcomes

  1. Heart Rate Variability Stress Index [a.u.]

    Stress Level changes assessed by ECG HRV measurements before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  2. Heart Rate Variability meanRR [ms]

    Average of RR-intervals array assessed by ECG HRV measurements before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  3. Heart Rate Variability Total Power [ms^2]

    Total Power of RR-intervals array spectrogram assessed by ECG HRV measurements before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  4. Heart Rate Variability SDNN [ms]

    SDNN value of RR-intervals array assessed by ECG HRV measurements before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  5. Heart Rate Variability RMSSD [ms]

    RMSSD value of RR-intervals array assessed by ECG HRV measurements before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

  6. EEG spectral power in beta frequency range, [uV^2]

    Electrical spectral density in beta frequency range of brain activity measured before, just after and 10 minutes after auditory stimulation

    Time frame: The outcome measure will be assessed between 5-minute intervals before stimulation, just after and 10 minutes after stimulation

07

Study locations

1 of 1 sites recruiting
  • Oles Honchar Dnipro National University
    Dnipro, Dnipropetrovska 49010, Ukraine
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05339906
Lead sponsor
Oles Honchar Dnipro National University
Collaborators
SynthezAI Corp.
Responsible party
Dmytro Chernetchenko (PhD, Associate Professor, Oles Honchar Dnipro National University) — Principal investigator
First posted
Apr 21, 2022
Start date
May 25, 2021
Primary completion
Dec 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Apr 21, 2022

Study contacts

Dmytro V Chernetchenko, PhD
Contact
d.chernetchenko@zov.ai
+380504208604
Dmytro Lituiev, PhD
study chair · SynthezAI Corp.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion